121 related articles for article (PubMed ID: 1793828)
1. Effects in vivo of purified recombinant human activin and erythropoietin in mice.
Broxmeyer HE; Hangoc G; Zucali JR; Mason A; Schwall R; Carow C; Cooper S
Int J Hematol; 1991 Dec; 54(6):447-54. PubMed ID: 1793828
[TBL] [Abstract][Full Text] [Related]
2. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
[TBL] [Abstract][Full Text] [Related]
3. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
4. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
5. Effects in vivo of recombinant human inhibin on myelopoiesis in mice.
Hangoc G; Carow CE; Schwall R; Mason AJ; Broxmeyer HE
Exp Hematol; 1992 Nov; 20(10):1243-6. PubMed ID: 1426104
[TBL] [Abstract][Full Text] [Related]
6. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
7. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.
Broxmeyer HE; Lu L; Cooper S; Ruggieri L; Li ZH; Lyman SD
Exp Hematol; 1995 Sep; 23(10):1121-9. PubMed ID: 7544740
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
9. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of in vivo murine erythropoietic response to sodium orthovanadate.
Aguirre MV; Juaristi JA; Alvarez MA; Brandan NC
Chem Biol Interact; 2005 Sep; 156(1):55-68. PubMed ID: 16137666
[TBL] [Abstract][Full Text] [Related]
11. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
Mitjavila MT; Natazawa M; Brignaschi P; Debili N; Breton-Gorius J; Vainchenker W
J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773
[TBL] [Abstract][Full Text] [Related]
12. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
13. Effects of an aplastic anemia urinary extract on mouse erythroid progenitor cells in vivo.
Kamamoto T; Kuriya S; Murphy MJ
Exp Hematol; 1988 May; 16(4):268-73. PubMed ID: 3360064
[TBL] [Abstract][Full Text] [Related]
14. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
15. Erythroid progenitor cells (CFU-E*) from Friend virus-infected mice undergo 55Fe suicide in vitro in the absence of added erythropoietin.
Del Rizzo DF; Axelrad AA
Exp Hematol; 1985 Nov; 13(10):1055-61. PubMed ID: 4054246
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
17. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
[TBL] [Abstract][Full Text] [Related]
18. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
20. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
